Literature DB >> 30848892

Enantioselective Divergent Synthesis of C19-Oxo Eburnane Alkaloids via Palladium-Catalyzed Asymmetric Allylic Alkylation of an N-Alkyl-α,β-unsaturated Lactam.

Barry M Trost1, Yu Bai1, Wen-Ju Bai1, Johnathan E Schultz1.   

Abstract

The C19-oxo-functionalized eburnane alkaloids display unique chemical structure and interesting biological activity. Herein, we report a divergent enantioselective strategy to access these alkaloids by use of a challenging palladium-catalyzed asymmetric allylic alkylation of an N-alkyl-α,β-unsaturated lactam. 19-( S)-OH-Δ14-vincamone (phutdonginin), (-)-19-OH-eburnamine, (+)-19-oxoeburnamine, and (+)-19-OH-eburnamonine (1-4) have been concisely synthesized for the first time in 11 to 13 steps.

Entities:  

Year:  2019        PMID: 30848892     DOI: 10.1021/jacs.9b00788

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

Review 1.  Recent Advances in the Synthesis of β-Carboline Alkaloids.

Authors:  Tímea Szabó; Balázs Volk; Mátyás Milen
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

2.  Late-Stage Chemoenzymatic Installation of Hydroxy-Bearing Allyl Moiety on the Indole Ring of Tryptophan-Containing Peptides.

Authors:  Nagaraju Mupparapu; Lauren Brewster; Katrina F Ostrom; Sherif I Elshahawi
Journal:  Chemistry       Date:  2022-03-10       Impact factor: 5.020

3.  The Enantioselective Synthesis of Eburnamonine, Eucophylline, and 16'-epi-Leucophyllidine.

Authors:  Christopher E Reimann; Aurapat Ngamnithiporn; Kohei Hayashida; Daisuke Saito; Katerina M Korch; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2021-07-06       Impact factor: 16.823

4.  Pd/BIPHEPHOS is an Efficient Catalyst for the Pd-Catalyzed S-Allylation of Thiols with High n-Selectivity.

Authors:  Thomas Schlatzer; Hilmar Schröder; Melanie Trobe; Christian Lembacher-Fadum; Simon Stangl; Christoph Schlögl; Hansjörg Weber; Rolf Breinbauer
Journal:  Adv Synth Catal       Date:  2019-11-07       Impact factor: 5.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.